Reata Pharmaceuticals (RETA) PT Raised to $39 at Citi
Tweet Send to a Friend
Citi raised its price target on Reata Pharmaceuticals (NASDAQ: RETA) to $39.00 (from $32.00) while maintaining a Buy rating.Analyst Dr ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
